Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT01172431

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01172431
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01172431. Randomized; no masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
Condition
Hypertension
Condition
Renal Insufficiency
Intervention (Drug)
Indapamide
Intervention (Drug)
Hydrochlorothiazide
Lead sponsor
West China Hospital (class: other)

Record details

Record id
cardio:ct-nct01172431
Content hash
95e3ba3deae49a5be5b0ee9763078b08eaeeca7c78ff4ace0b87f1d58831265a